Press Releases

Posted May 27, 2021

LJI and Synbal, Inc. partner to develop better COVID-19 models

New mouse models may shed light on the puzzling aspects of SARS-CoV-2 infection May 27, 2021 LA JOLLA—The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical [...]

By Synbal

In Press Releases

Posted March 31, 2019

Synbal: Gene Driving on Parallel Tracks

BIOCENTURY | EMERGING COMPANY PROFILE BY MARK ZIPKIN, STAFF WRITER Synbal is tapping new genetic approaches to develop both rodents with humanized metabolisms and cell therapies for lysosomal [...]

By Synbal

In Press Releases

Posted February 6, 2019

Drs. K. Cooper, V. Gantz and E. Bier have published another landmark paper in the journal Nature

Synbal is proud to announce that several members of our Scientific Advisory Board, Drs. K. Cooper, V. Gantz and E. Bier have published another landmark paper in the journal Nature. The paper [...]

By Synbal

In Press Releases

Posted November 26, 2018

Synbal Joins BioLabs San Diego with a Fast-Track SBIR Grant from the NCI

SAN DIEGO, Calif., November 26, 2018—Synbal, Inc., a biotechnology company developing non-viral, cell-based gene therapy candidates for rare diseases, cancer, autoimmune and degenerative [...]